View in EDS

Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.

Saved in:
Bibliographic Details
Title: Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.
Authors: Murai J; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.; Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.; Department of Cell Growth and Tumor Regulation, Proteo-Science Center, Ehime University, Toon, Japan.; Department of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Toon, Japan., Ceribelli M; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland., Fu H; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Redon CE; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Jo U; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Murai Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Aladjem MI; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Thomas CJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland., Pommier Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2023 Aug 01; Vol. 22 (8), pp. 985-995.
Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37216280
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Murai+J%22">Murai J</searchLink>; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.; Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.; Department of Cell Growth and Tumor Regulation, Proteo-Science Center, Ehime University, Toon, Japan.; Department of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Toon, Japan.<br /><searchLink fieldCode="AU" term="%22Ceribelli+M%22">Ceribelli M</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Fu+H%22">Fu H</searchLink>; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Redon+CE%22">Redon CE</searchLink>; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Jo+U%22">Jo U</searchLink>; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Murai+Y%22">Murai Y</searchLink>; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Aladjem+MI%22">Aladjem MI</searchLink>; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Thomas+CJ%22">Thomas CJ</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Pommier+Y%22">Pommier Y</searchLink>; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2023 Aug 01; Vol. 22 (8), pp. 985-995.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37216280
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-22-0552
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 985
    Titles:
      – TitleFull: Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Murai J
      – PersonEntity:
          Name:
            NameFull: Ceribelli M
      – PersonEntity:
          Name:
            NameFull: Fu H
      – PersonEntity:
          Name:
            NameFull: Redon CE
      – PersonEntity:
          Name:
            NameFull: Jo U
      – PersonEntity:
          Name:
            NameFull: Murai Y
      – PersonEntity:
          Name:
            NameFull: Aladjem MI
      – PersonEntity:
          Name:
            NameFull: Thomas CJ
      – PersonEntity:
          Name:
            NameFull: Pommier Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2023 Aug 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1